Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



GRYSKA DAVID W Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 4 GRYSKA DAVID W (Director) has filed a Form 4 on Forte Biosciences, Inc.
Txns: Granted 148,514 shares @ $1.01, valued at $150k
06/02/2023 4 GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
01/12/2023 4 GRYSKA DAVID W (Director) has filed a Form 4 on Forte Biosciences, Inc.
Txns: Granted 50,000 options to buy @ $1.02, valued at $51k
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/13/2022 4 GRYSKA DAVID W (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 6,245 shares @ $0
Granted 16,854 options to buy @ $6.11, valued at $103k
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2022 4 GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 1,794 shares @ $143.32, valued at $257.1k
Sold 1,516 shares @ $144.17, valued at $218.6k
Sold 690 shares @ $145.08, valued at $100.1k
Exercised 1,794 options to buy @ $20.06, valued at $36k
Exercised 1,516 options to buy @ $20.06, valued at $30.4k
Exercised 690 options to buy @ $20.06, valued at $13.8k
02/09/2022 4 GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 1,100 shares @ $137.45, valued at $151.2k
Sold 1,029 shares @ $138.66, valued at $142.7k
Sold 2,371 shares @ $139.42, valued at $330.6k
Exercised 1,100 options to buy @ $20.06, valued at $22.1k
Exercised 1,029 options to buy @ $20.06, valued at $20.6k
Exercised 2,371 options to buy @ $20.06, valued at $47.6k
02/01/2022 4 GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 850 shares @ $121.69, valued at $103.4k
Sold 2,553 shares @ $122.43, valued at $312.6k
Sold 883 shares @ $123.39, valued at $109k
Sold 214 shares @ $124.23, valued at $26.6k
Exercised 850 options to buy @ $20.06, valued at $17.1k
Exercised 2,553 options to buy @ $20.06, valued at $51.2k
Exercised 883 options to buy @ $20.06, valued at $17.7k
Exercised 214 options to buy @ $20.06, valued at $4.3k
01/19/2022 4 GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 4,500 shares @ $135.2402, valued at $608.6k
Exercised 4,500 options to buy @ $20.06, valued at $90.3k
06/21/2021 4 GRYSKA DAVID W (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 1,750 shares @ $0
Granted 7,800 options to buy @ $16.21, valued at $126.4k
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/07/2021 4 GRYSKA DAVID W (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Disposed/sold 35,208 options to buy @ $0.0017, valued at $59.9
Disposed/sold 22,464 options to buy @ $0.0017, valued at $38.2
02/24/2021 4 GRYSKA DAVID W (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Granted 22,464 options to buy @ $0
12/31/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/17/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns: Sold 75,000 shares @ $2.68, valued at $201k
12/09/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns: Exercised 66,050 options to buy @ $1.64, valued at $108.3k
12/04/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns: Sold 75,000 shares @ $2.52, valued at $189k
11/24/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns: Sold 50,000 shares @ $2.43, valued at $121.5k
11/23/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 7,129 shares @ $174.2, valued at $1.2M
Sold 7,871 shares @ $173.25, valued at $1.4M
Exercised 7,129 options to buy @ $19.02, valued at $135.6k
Exercised 7,871 options to buy @ $19.02, valued at $149.7k
11/20/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns: Exercised 60,000 options to buy @ $1.64, valued at $98.4k
11/19/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns: Sold 100,000 shares @ $2.4, valued at $240k
Sold 50,000 shares @ $2.39, valued at $119.5k
11/06/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 4,500 shares @ $180.5998, valued at $812.7k
09/16/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC
Txns: Granted 35,208 options to buy @ $0.0017, valued at $59.9
08/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 1,750 shares @ $0
Granted 7,800 options to buy @ $13.27, valued at $103.5k
05/19/2020 4 GRYSKA DAVID W (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 1,335 shares @ $0
Granted 3,171 options to buy @ $160.33, valued at $508.4k
10/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2019 4 GRYSKA DAVID W (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Sold 5,000 shares @ $75, valued at $375k
Exercised 5,000 options to buy @ $12.76, valued at $63.8k
06/24/2019 4 GRYSKA DAVID W (Director) has filed a Form 4 on PDL BIOPHARMA, INC.
Txns: Granted 126,050 options to buy @ $3, valued at $378.2k
05/23/2019 4 GRYSKA DAVID W (Director) has filed a Form 4 on AERIE PHARMACEUTICALS INC
Txns: Granted 1,750 shares @ $0
Granted 7,800 options to buy @ $39.44, valued at $307.6k
05/22/2019 4 GRYSKA DAVID W (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 2,963 shares @ $0
Granted 7,038 options to buy @ $64.38, valued at $453.1k
04/03/2019 4 GRYSKA DAVID W (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Sold 4,794 shares @ $73.38, valued at $351.8k
Sold 206 shares @ $74.01, valued at $15.2k
Exercised 5,000 options to buy @ $12.76, valued at $63.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy